Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANDREW A WHITE

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1750352761
CMS profile
79540
Location
SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$189,932.79

293 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 6; records 51–100 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANDREW A WHITE

NPI 1750352761 · CMS profile ID 79540

Allopathic & Osteopathic Physicians / Allergy & Immunology

SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 6; records 51–100 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1750352761?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANDREW A WHITE, NPI 1750352761, CMS profile ID 79540. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750352761?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ANDREW A WHITE, NPI 1750352761, CMS profile ID 79540. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750352761?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ANDREW A WHITE, NPI 1750352761, CMS profile ID 79540, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 6; records 51–100 of 293 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1750352761?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

293 matching records · $189,932.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 293 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 293.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Blueprint Medicines Corporation $80.0011/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257273 CMS
GlaxoSmithKline, LLC. $29.8810/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002832953 CMS
AstraZeneca Pharmaceuticals LP $1,050.0010/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011342229 CMS
Blueprint Medicines Corporation $276.1210/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257265 CMS
Blueprint Medicines Corporation $76.8610/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257277 CMS
GlaxoSmithKline, LLC. $27.2310/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002857423 CMS
Regeneron Healthcare Solutions, Inc. $23.2510/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999537265 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.1910/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055666743 CMS
GlaxoSmithKline, LLC. $1,839.4010/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002833023 CMS
GlaxoSmithKline, LLC. $26.2510/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002830683 CMS
GENZYME CORPORATION $2,473.0010/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049916131 CMS
GENZYME CORPORATION $5.6910/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049916103 CMS
AstraZeneca Pharmaceuticals LP $800.0010/09/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015605903 CMS
ALK-Abello, Inc $24.7010/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017137833 CMS
GlaxoSmithKline, LLC. $1,300.0010/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002861485 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.2110/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055666737 CMS
GlaxoSmithKline, LLC. $1,950.0010/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002853393 CMS
LEO Pharma Inc. $29.7710/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053542795 CMS
Blueprint Medicines Corporation $616.0010/02/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257319 CMS
Blueprint Medicines Corporation $954.0010/02/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257323 CMS
Grifols USA, LLC $13.0609/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011798317 CMS
Regeneron Healthcare Solutions, Inc. $29.9909/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999537257 CMS
GENZYME CORPORATION $1,649.0009/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049916119 CMS
GlaxoSmithKline, LLC. $123.9209/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002834967 CMS
Genentech USA, Inc. $25.5609/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040296537 CMS
GlaxoSmithKline, LLC. $24.7909/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002855307 CMS
GlaxoSmithKline, LLC. $24.8709/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002857483 CMS
GlaxoSmithKline, LLC. $421.0509/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002859513 CMS
Genentech USA, Inc. $19.5409/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040296547 CMS
Genentech USA, Inc. $1.2309/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040296555 CMS
Optinose US, Inc. $12.5809/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035108035 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.8509/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055666731 CMS
GlaxoSmithKline, LLC. $5,200.0009/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002855363 CMS
Blueprint Medicines Corporation $2.1109/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257205 CMS
Blueprint Medicines Corporation $26.5709/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257209 CMS
Blueprint Medicines Corporation $1,272.0009/19/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051257475 CMS
GENZYME CORPORATION $2.8409/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049916081 CMS
GlaxoSmithKline, LLC. $27.2309/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002830885 CMS
GlaxoSmithKline, LLC. $97.7409/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002859367 CMS
GlaxoSmithKline, LLC. $1,561.2409/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002859431 CMS
AstraZeneca Pharmaceuticals LP $123.5009/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016175869 CMS
Regeneron Healthcare Solutions, Inc. $110.2809/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999537249 CMS
Regeneron Healthcare Solutions, Inc. $934.1509/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999537231 CMS
Regeneron Healthcare Solutions, Inc. $141.3009/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999537241 CMS
GlaxoSmithKline, LLC. $1,300.0008/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002836625 CMS
CSL Behring $19.2108/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042914867 CMS
Genentech USA, Inc. $10.0708/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040296531 CMS
Regeneron Healthcare Solutions, Inc. $17.9408/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999537223 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9.2508/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055666725 CMS
Genentech USA, Inc. $20.9508/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040296617 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $62,326.33 171
PY2020 $35,579.12 83
PY2021 $51,213.84 165
PY2022 $120,510.98 252
PY2023 $189,932.79 293
PY2024 $145,660.00 277
PY2025 $147,061.26 278

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $4,413.62 5
PY2025 Principal investigator $237,964.60 8
PY2024 Principal investigator $55,850.97 5
PY2023 Principal investigator $16,171.64 8
PY2021 Principal investigator $7,130.00 1
PY2020 Recipient $959.09 2
PY2020 Principal investigator $107,755.00 3
PY2019 Principal investigator $38,640.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Regeneron Pharmaceuticals, Inc. $475.00 12/01/2025 Covered Recipient Physician DUPIXENT CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184123908
Recipient Regeneron Pharmaceuticals, Inc. $309.38 12/01/2025 Covered Recipient Physician DUPIXENT CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184123910
Recipient Regeneron Pharmaceuticals, Inc. $1,768.85 11/01/2025 Covered Recipient Physician DUPIXENT CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184123906
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,100.00 10/08/2025 Covered Recipient Teaching Hospital
SCRIPPS MERCY HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184137001
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $56,271.28 10/08/2025 Covered Recipient Teaching Hospital
SCRIPPS MERCY HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184137003
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,100.00 05/14/2025 Covered Recipient Teaching Hospital
SCRIPPS MERCY HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184136969
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37,489.24 05/14/2025 Covered Recipient Teaching Hospital
SCRIPPS MERCY HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184136971
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18,744.62 05/14/2025 Covered Recipient Teaching Hospital
SCRIPPS MERCY HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184136973
Recipient Regeneron Pharmaceuticals, Inc. $1,021.50 03/01/2025 Covered Recipient Physician DUPIXENT CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184123904
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $63,263.10 01/08/2025 Covered Recipient Teaching Hospital
SCRIPPS GREEN HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184136935
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,762.50 01/08/2025 Covered Recipient Teaching Hospital
SCRIPPS MERCY HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184136951
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $56,233.86 01/08/2025 Covered Recipient Teaching Hospital
SCRIPPS MERCY HOSPITAL
MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES No dispute reported 06/30/2026 1184136953
Recipient Regeneron Pharmaceuticals, Inc. $838.89 01/01/2025 Covered Recipient Physician DUPIXENT CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184123902